Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRL

Charles River Laboratories International Inc

May 29 • 04:00PM ET

180.71

-0.63 -0.35 %

Healthcare • Diagnostics & Research • USA • Mid • NYSE

Peers: ICLR IQV MEDP LH DGX TMO A DHR WAT BIO

| Held by: VTI VOO VB RSP VBR IVV SPY IBB XLV DFAT

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-3.76	Insider Own	1.11%	Shs Outstand	48.17M	Perf Week	13.75%
Market Cap	8.70B	Forward P/E	14.66	EPS next Y	12.32	Insider Trans	-0.07%	Shs Float	47.63M	Perf Month	10.30%
Enterprise Value	11.62B	PEG	1.55	EPS next Q	2.73	Inst Own	121.08%	Short Float	7.63%	Perf Quarter	1.24%
Income	-184.65M	P/S	2.16	EPS this Y	7.92%	Inst Trans	11.50%	Short Ratio	4.05	Perf Half Y	1.49%
Sales	4.03B	P/B	2.96	EPS next Y	11.09%	ROA	-2.41%	Short Interest	3.63M	Perf YTD	-9.41%
Book/sh	61.05	P/C	44.92	EPS next 5Y	9.49%	ROE	-6.02%	52W High	228.88 -21.05%	Perf Year	31.23%
Cash/sh	4.02	P/FCF	22.25	EPS past 3/5Y	- -	ROIC	-3.08%	52W Low	132.58 36.30%	Perf 3Y	-6.91%
Dividend Est.	-	EV/EBITDA	13.32	Sales past 3/5Y	0.33% 6.55%	Gross Margin	31.25%	Volatility	5.83% 5.37%	Perf 5Y	-46.53%
Dividend TTM	-	EV/Sales	2.89	EPS Y/Y TTM	-492.25%	Oper. Margin	12.98%	ATR (14)	8.78	Perf 10Y	110.03%
Dividend Ex-Date	-	Quick Ratio	1.03	Sales Y/Y TTM	0.11%	Profit Margin	-4.59%	RSI (14)	60.98	Recom	1.90
Dividend Gr. 3/5Y	- -	Current Ratio	1.36	EPS Q/Q	-160.54%	SMA20	8.36%	Beta	1.46	Target Price	217.79
Payout	-	Debt/Eq	1.04	Sales Q/Q	1.18%	SMA50	6.89%	Rel Volume	1.16	Prev Close	181.34
Employees	19700	LT Debt/Eq	1.04	Earnings	May 07 BMO	SMA200	2.51%	Avg Volume	896.14K	Price	180.71
IPO	Jun 23, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% 1.88%	Trades		Volume	1,040,673	Change	-0.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)